Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 07 06 2018
revised: 18 09 2018
accepted: 25 09 2018
pubmed: 16 11 2018
medline: 27 2 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

This natural experiment was designed to assess the impact of exposure to an active case of tuberculosis (TB) on a group of immunosuppressed individuals, with end-stage renal disease over an extended follow-up. Close contacts of people with sputum smear-positive Mycobacterium tuberculosis are at high risk of infection, particularly immunosuppressed individuals. An infectious TB healthcare worker worked in a renal dialysis unit for a month before diagnosis, with 104 renal dialysis patients, was exposed for ≥8 h. Patients were informed and invited for screening 8-10 weeks postexposure. They either underwent standard two-step assessment with tuberculin skin test (TST) and QuantiFERON Of 104 exposed individuals, 75 enrolled in the study. There was a high degree of discordance among QFN, TSPOT and TST. This was seen at both the first time point and also over time in subjects who were retested. No patients had active TB at the baseline testing. None received treatment for latent TB infection. Over the following 2 years, no one developed TB disease. This study suggests that there is a low risk of progression to active TB in low-incidence countries even in high-risk groups. This plus the degree of the test result discordance emphasises the complexities of managing TB in such settings as it is unclear which of these tests, if any, provides the best diagnostic accuracy.

Identifiants

pubmed: 30439554
pii: S0033-3506(18)30312-3
doi: 10.1016/j.puhe.2018.09.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-39

Informations de copyright

Copyright © 2018 The Royal Society for Public Health. All rights reserved.

Auteurs

J Southern (J)

Public Health England, London, United Kingdom. Electronic address: jo.southern@phe.gov.uk.

S Sridhar (S)

Imperial College London, United Kingdom.

C-Y Tsou (CY)

Public Health England, London, United Kingdom.

S Hopkins (S)

Royal Free London NHS Foundation Trust, United Kingdom.

S Collier (S)

Royal Free London NHS Foundation Trust, United Kingdom.

V Nikolayevskyy (V)

Public Health England, London, United Kingdom.

S Lozewicz (S)

North Middlesex University Hospital, United Kingdom.

A Lalvani (A)

Imperial College London, United Kingdom.

I Abubakar (I)

Public Health England, London, United Kingdom.

M Lipman (M)

University College London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH